What is Ledipasvir-sofosbuvir?

Category: Prescription Drugs

Most popular types: Harvoni Hepcvir-L


Ledipasvir-sofosbuvir is a combination of two antiviral medications used to treat chronic hepatitis C (CHC) genotype 1 infection in adults.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 1
Moderate 2
Mild 5
None 6

Commonly reported side effects and conditions associated with Ledipasvir-sofosbuvir

Side effect Patients Percentage
Headaches 4
Insomnia 2
Breathing difficulty 1
Chest pain 1
Constipation 1
Fatigue 1

Show all 12 reported side effects

Why patients stopped taking Ledipasvir-sofosbuvir

Multiple reasons could be selected

Reason Patients Percentage
Course of treatment ended 11
See all 11 patients who've stopped taking Ledipasvir-sofosbuvir


Stopped taking Ledipasvir-sofosbuvir

Duration Patients Percentage
1 - 6 months 10
6 months - 1 year 1
Adherence Evaluations Percentage
Always 13
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden Evaluations Percentage
Very hard to take 2
Somewhat hard to take 1
A little hard to take 2
Not at all hard to take 9
Cost per month
Cost per month Evaluations Percentage
$200+ 2
$100-199 0
$50-99 0
$25-49 0
< $25 11
Not specified 1

What people switch to and from

Patients started taking Ledipasvir-sofosbuvir after stopping:

Treatment Patients Percentage
Ribavirin 2
Peginterferon alfa-2b (PegIntron) 1
Ritonavir-dasabuvir-ombitasvir-paritaprevir 1
Telaprevir 1
Last updated:
There are no evaluations for Ledipasvir-sofosbuvir.